Archer PharmaVentures: Experts in deals and alliances
Drug Delivery Report E-News
Sontra Medical Corporation - Skin Permeation in 30 seconds or less - The New Wave of Transdermal Science
In order to ensure that you continue to receive information that is of interest from PharmaVentures help us by subscribing. Thank you for your co-operation.

Kick start your 2006 deal making activities


...The response from the advertisement and editorial on INNERCAP in the Drug Delivery Report has exceeded all expectations.

Fred H. Miller, President, INNERCAP Technologies, Inc

Find out how you can showcase your drug delivery opportunities to 8000+ key decision makers worldwide within the pharmaceutical and biotech sectors, both in print and via www.drugdeliveryreport.com.

If you want to complete a deal in 2006, then advertising in the Drug Delivery Report is a must.
Download media planner here.

Market News and Trends

During December 2005, PharmaDeals Agreements recorded 20 deals that related to drug delivery. These comprised the expected mix of business acquisitions, licensing agreements and co-development partnerships. The majority of the deals involved alliances between start-up/emerging companies, and had the aim of advancing innovative delivery technologies by applying them to a range of pharmaceutical products. However, three deals involved global companies, including Johnson & Johnson's agreement to acquire Animas through its subsidiary LifeScan. This deal gave LifeScan immediate entry into the fast-growing insulin delivery pump market. Read more...

Featured Article

Current Ocular Drug Delivery Challenges
The need for ophthalmic medications is continuously increasing as the populations of the industrialised nations age. The development of new products for treatment of ophthalmic diseases is facing a double challenge: pharmacology and drug delivery. In this article, Laura Rabinovich-Guilatt and Gregory Lambert of Novagali Pharma SA discuss the main difficulties involved in delivering drugs to the eye: lipophilic molecules must be delivered in ointments which, because of their viscosity and the resulting disrupted vision, must be applied at night and topically applied drugs have a low ocular bioavailability. Read more...

Company Profiles

MedPharm, Octoplus, Pfeiffer, Sigmoid

Drug Delivery Opportunities

View all our Drug Delivery Opportunities or alternatively request a password to submit your opportunity online.

Featured Opportunity

Improved Vaccine Delivery: Virus-Like Particles
Administrative route - Undisclosed
Indication - HIV, hepatitis B, hepatitis C, allergies, cancer
Licence code LO-1105-16

DDR cover

Ensure you receive your copy of the Drug Delivery Companies Spring / Summer 2006

For deal makers actively assessing drug delivery technology receiving your complimentary copy is a must. The DDR blends high-quality articles covering the latest drug developments in conjunction with concise profiles of companies active in specific technology areas.

Apply to receive the next edition of the DDR

Find out more about promoting your company
Drug Delivery E-News is produced by PharmaVentures Intelligence - part of PharmaVentures a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making.

Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence - we work with clients to drive greater value from their deals.

If you do not wish to receive DDR E-News in future, please e-mail ddr@pharmamail.biz with the words UNSUBSCRIBE as the subject.

If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddr@pharmamail.biz with REMOVE as the subject.

For more details contact
Kate Atherton, Publishing Editor, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail ddr@pharmamail.biz
www.drugdeliveryreport.com